… Thompson e g … true brain-behavior effect sizes are smaller than have been described in the
past (Paulus and Thompson, 2019; Kendler, 2019). Indeed, Ioannidis (2005) (Ioannidis, 2005…

The goal of pharmacovigilance is to detect, monitor, characterize and prevent adverse drug
events (ADEs) with pharmaceutical products. This article is a comprehensive structured …

Magnetic resonance imaging (MRI) has transformed our understanding of the human brain
through well-replicated mapping of abilities to specific structures (for example, lesion studies) …

In recent years, genome-wide association study (GWAS) sample sizes have become larger,
the statistical power has improved and thousands of trait-associated variants have been …

… typically require ~2 h to complete, including a mid-session rest break if the child requests
one; they are sometimes split into two separate sessions that take place within one week of …

Objective There is growing public health interest in understanding and promoting successful
aging. While there has been some exciting empirical work on objective measures of …

Several lines of evidence suggest that genome-wide association studies (GWASs) have the
potential to explain more of the "missing heritability" of common complex phenotypes. …

Primary sclerosing cholangitis (PSC) is a severe liver disease of unknown etiology leading to
fibrotic destruction of the bile ducts and ultimately to the need for liver transplantation 1 , 2 , …

Background Identifying individuals at risk for developing Alzheimer disease (AD) is of utmost
importance. Although genetic studies have identified AD-associated SNPs in APOE and …

Objective: Genome-wide association studies (GWAS) require high specificity and large numbers
of subjects to identify genotype–phenotype correlations accurately. The aim of this study …